Inventiva S.A. Files July 2024 Report (6-K)
Ticker: IVEVF · Form: 6-K · Filed: Jul 5, 2024 · CIK: 1756594
| Field | Detail |
|---|---|
| Company | Inventiva S.A. (IVEVF) |
| Form Type | 6-K |
| Filed Date | Jul 5, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, regulatory-filing, pharmaceuticals
TL;DR
Inventiva S.A. filed its July 6-K, standard procedure for investors.
AI Summary
Inventiva S.A. filed a Form 6-K on July 5, 2024, to report its activities for the month of July 2024. The company, incorporated in France, is a pharmaceutical preparations company and is submitting its report under the 1934 Securities Exchange Act. Inventiva S.A. is required to file annual reports under Form 20-F.
Why It Matters
This filing provides routine updates on Inventiva S.A.'s corporate activities, which is important for investors to stay informed about the company's ongoing operations and compliance.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that does not appear to contain significant new financial or operational information.
Key Players & Entities
- Inventiva S.A. (company) — Registrant
- 001-39374 (company) — SEC File Number
- 2834 (company) — Standard Industrial Classification (Pharmaceutical Preparations)
- July 2024 (date) — Reporting Period
- July 5, 2024 (date) — Filing Date
FAQ
What type of report is Inventiva S.A. filing?
Inventiva S.A. is filing a Form 6-K, which is a Report of Foreign Private Issuer.
What is the reporting period for this Form 6-K?
The reporting period is for the month of July 2024.
What is Inventiva S.A.'s SEC file number?
Inventiva S.A.'s SEC file number is 001-39374.
Does Inventiva S.A. file annual reports under Form 20-F or 40-F?
Inventiva S.A. indicates it files annual reports under cover of Form 20-F.
What is the primary business of Inventiva S.A. according to the filing?
Inventiva S.A. is classified under Standard Industrial Classification 2834, which is Pharmaceutical Preparations.
Filing Stats: 186 words · 1 min read · ~1 pages · Grade level 9.2 · Accepted 2024-07-05 16:21:36
Filing Documents
- f6k_070524.htm (6-K) — 5KB
- exh_991.htm (EX-99.1) — 24KB
- 0001171843-24-003822.txt ( ) — 30KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Inventiva S.A. (Registrant) Date: July 5, 2024 /s/ Frdric Cren Frdric Cren Chief Executive Officer